About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
The COVID-19 pandemic has demonstrated that we need to build a more resilient health care system that is well positioned to prevent and respond to infectious disease outbreaks and other public health crises and natural disasters. Achieving this goal will require addressing the growing threat of antimicrobial resistance (AMR).
The discovery and introduction of antibiotics in the 1940s transformed modern medicine and enabled tremendous progress in health care and life expectancy. Today, this progress is increasingly threatened by AMR. AMR is a natural process that occurs when microorganisms such as bacteria, viruses, fungi and parasites change in ways that make the microorganisms resistant to the medication used to cure the infection. This means the more we use medicines to fight these infections, the more resistance we create.
addressing growing public health emergency preview
Fact Sheet
2022 Industry Profile Toolkit: Addressing a Growing Public Health Emergency: Antimicrobial Resistance
addressing growing public health emergency preview